The FDA fast-tracked review of psilocybin and methylone for mental health treatment, cutting timelines to 1-2 months under a new executive order that includes $50M in research funding.
https://www.cnn.com/2026/04/24/health/fda-psychedelic-drugs-priority-vouchers
#Psilocybin #Entheogen #MentalHealth
https://www.cnn.com/2026/04/24/health/fda-psychedelic-drugs-priority-vouchers
#Psilocybin #Entheogen #MentalHealth